Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
4 followers
Gilead Sciences
199 followers
Regeneron
164 followers
Illumina
86 followers
Agilent Technologies
96 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
53 followers